BDNF and fibromyalgia: Specifically, the ABCT has shown its efficacy and applicability for the treatment of fibromyalgia showing improvements on psychological outcomes such as functional status [34] and biological outcomes such as reduced brain-derived neurotrophic factor (BDNF) and inflammatory biomarkers [35].